Secondary external-beam radiotherapy and hyperthermia for local recurrence after 125-iodine implantation in adenocarcinoma of the prostate.
At Stanford, six patients underwent a course of external radiotherapy after local recurrence following 125-iodine implantation. Four of the six patients also received concomitant hyperthermia. Four patients were initially managed with hormonal manipulation at time of local relapse and subsequently received external beam radiotherapy with or without hyperthermia. The hyperthermia was non-invasively induced using an annular phased array radiative electromagnetic system. Treatment was well tolerated, and none of the patients experienced severe rectal or bladder complications. Three patients are free from disease; one patient experience local-regional recurrence based on biopsy; one recurred in the bladder, was treated with cystoprostatectomy and subsequently succumbed to metastatic disease; and one patient died of presumed metastatic disease. External-beam irradiation with concurrent hyperthermia can be safely delivered to treat locally recurrent prostatic carcinoma after 125-iodine implantation.
Kaplan
I
I
Department of Radiation Oncology, Stanford University School of Medicine, CA 94305.
Kapp
D S
DS
Bagshaw
M A
MA
D000230:Adenocarcinoma / Q000532:radiotherapy / Q000628:therapy*; D001918:Brachytherapy; D003131:Combined Modality Therapy; D006801:Humans; D006979:Hyperthermia, Induced; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000532:radiotherapy / Q000628:therapy*; D011471:Prostatic Neoplasms / Q000532:radiotherapy / Q000628:therapy*; D011879:Radiotherapy Dosage
D007457:Iodine Radioisotopes